Ingenix Raises €13m From Sofinnova Partners-Led Syndicate to Scale Modality Fusion, a Novel Architecture for Drug Development

Ingenix’s Biological Reasoning Engine fuses biological data through Modality Fusion, a new architecture for AI in drug development